| Charles Henry Hunt Iii, | |
|
4151 Foothill Rd, Santa Barbara, CA 93110 | |
| (805) 681-7636 | |
| Not Available |
| Full Name | Charles Henry Hunt Iii |
|---|---|
| Gender | Male |
| Speciality | Qualified Audiologist |
| Experience | 6 Years |
| Location | 4151 Foothill Rd, Santa Barbara, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649735044 | NPI | - | NPPES |
| AU3375 | Other | CA | MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 3375 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sansum Clinic | 3678471976 | 276 |
News Archive
VOA News reports that fake pharmaceuticals pose a greater risk to stability and human security in West Africa than illegal drug trafficking, according to U.N. Office Against Drugs and Crime report. More than half of the malaria medication available in West Africa is of "sub-standard quality," according to U.N. estimates, VOA News writes, adding, "West Africa has the highest estimated rate of malaria on the continent, with nearly 98 million cases of malaria per year."
Researchers at the University of California Los Angeles (UCLA) have found that a second molecular pathway may need to be blocked to prevent malignant cells from creating new blood vessels [angiogenesis]. A study of patients with pancreatic cancer showed that CXCL5 may be a key molecule in the angiogenesis switch—the point at which cells stop being normal and start producing blood vessels that feed malignancy.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has entered into an exclusive agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI), to market the authorized generic version of Concerta® (methylphenidate hydrochloride extended-release tablets). Watson will launch its authorized generic of Concerta on May 1, 2011. Concerta is indicated for the treatment of attention deficit hyperactivity disorder (ADHD).
The American Association of Clinical Endocrinologists today announced the publication of its comprehensive diabetes management algorithm created to guide primary care physicians, endocrinologists and other health care professionals in the treatment of prediabetes and type 2 diabetes mellitus patients.
› Verified 2 days ago
| Provider Name | Sansum Clinic |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1154354504 PECOS PAC ID: 3678471976 Enrollment ID: O20031223000607 |
News Archive
VOA News reports that fake pharmaceuticals pose a greater risk to stability and human security in West Africa than illegal drug trafficking, according to U.N. Office Against Drugs and Crime report. More than half of the malaria medication available in West Africa is of "sub-standard quality," according to U.N. estimates, VOA News writes, adding, "West Africa has the highest estimated rate of malaria on the continent, with nearly 98 million cases of malaria per year."
Researchers at the University of California Los Angeles (UCLA) have found that a second molecular pathway may need to be blocked to prevent malignant cells from creating new blood vessels [angiogenesis]. A study of patients with pancreatic cancer showed that CXCL5 may be a key molecule in the angiogenesis switch—the point at which cells stop being normal and start producing blood vessels that feed malignancy.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has entered into an exclusive agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI), to market the authorized generic version of Concerta® (methylphenidate hydrochloride extended-release tablets). Watson will launch its authorized generic of Concerta on May 1, 2011. Concerta is indicated for the treatment of attention deficit hyperactivity disorder (ADHD).
The American Association of Clinical Endocrinologists today announced the publication of its comprehensive diabetes management algorithm created to guide primary care physicians, endocrinologists and other health care professionals in the treatment of prediabetes and type 2 diabetes mellitus patients.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles Henry Hunt Iii, Po Box 62106, Santa Barbara, CA 93160-2106 Ph: () - | Charles Henry Hunt Iii, 4151 Foothill Rd, Santa Barbara, CA 93110 Ph: (805) 681-7636 |
News Archive
VOA News reports that fake pharmaceuticals pose a greater risk to stability and human security in West Africa than illegal drug trafficking, according to U.N. Office Against Drugs and Crime report. More than half of the malaria medication available in West Africa is of "sub-standard quality," according to U.N. estimates, VOA News writes, adding, "West Africa has the highest estimated rate of malaria on the continent, with nearly 98 million cases of malaria per year."
Researchers at the University of California Los Angeles (UCLA) have found that a second molecular pathway may need to be blocked to prevent malignant cells from creating new blood vessels [angiogenesis]. A study of patients with pancreatic cancer showed that CXCL5 may be a key molecule in the angiogenesis switch—the point at which cells stop being normal and start producing blood vessels that feed malignancy.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has entered into an exclusive agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI), to market the authorized generic version of Concerta® (methylphenidate hydrochloride extended-release tablets). Watson will launch its authorized generic of Concerta on May 1, 2011. Concerta is indicated for the treatment of attention deficit hyperactivity disorder (ADHD).
The American Association of Clinical Endocrinologists today announced the publication of its comprehensive diabetes management algorithm created to guide primary care physicians, endocrinologists and other health care professionals in the treatment of prediabetes and type 2 diabetes mellitus patients.
› Verified 2 days ago
Dr. Ira J Nadell, PH.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 215 W Pueblo St, Santa Barbara, CA 93105 Phone: 805-563-1134 Fax: 805-563-8388 | |
Dodero Hearing Center Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1801 State St, #a, Santa Barbara, CA 93101 Phone: 805-687-4508 Fax: 805-687-5879 | |
Legacy Audiology, Inc. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5360 Hollister Ave Ste 1, Santa Barbara, CA 93111 Phone: 805-696-6811 Fax: 805-696-6453 | |
Hearing Consultants Of California Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5360 Hollister Ave #1, Santa Barbara, CA 93111 Phone: 805-696-6811 Fax: 805-696-6453 | |
Dr. Nicole Lynn Schmidt, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 5333 Hollister Ave Ste 165, Santa Barbara, CA 93111 Phone: 805-967-4200 | |
Aubree Janelle Newman, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 5360 Hollister Ave Ste 1, Santa Barbara, CA 93111 Phone: 805-696-6811 Fax: 805-696-6453 |